A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and effectiveness of two anti-HIV drug
combinations when given to HIV-infected patients who have never been treated with anti-HIV
drugs. One drug combination is stavudine (d4T) plus didanosine (ddI) plus Crixivan. The other
combination is Retrovir (AZT) plus Epivir (3TC) plus Crixivan.